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CHAPTER I 
 
INTRODUCTION 
The negative effects of smoking have been well documented over the last 40 
years (Hymowitz, 2005). In 2004, The Surgeon General and the Centers for Disease 
Control and Prevention (CDC) reported that smoking causes most cases of lung cancer 
(U.S. Department of Health and Human Services, 2004). In addition to lung cancer, 
cigarette smoke can cause cancer of the oral cavity, pharynx, larynx, and esophagus. 
Smoking also contributes to other pulmonary diseases including Chronic Obtrusive 
Pulmonary Disease (COPD). Recently, the CDC (2005) stated that smoking causes 
440,000 deaths in the United States alone. From a financial standpoint, cigarette smoke 
causes the United States 150 billion dollars each year. 
 Despite the clear health risks related to smoking, approximately 45.1 million 
adults in the United States are current smokers (CDC, 2005). However, adults are not the 
only individuals in the U.S. who are smoking cigarettes. The CDC (2003) report from the 
National Youth Tobacco Survey 13.3% of middle school and 28.4% of high school 
students use tobacco products. Despite these troubling findings and related health 
problems, cigarette smoking continues to be a problem in the United States. The goal of 
this paper is to review the relevant research on Nicotine Dependence including symptoms 
and treatment. In addition, new strategies for reducing cravings and withdrawal will be  
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discussed with special attention given to a biological indicator for determining a 
reduction in stress. 
 Avoiding or eliminating withdrawal symptoms is a key focus in the treatment of 
Nicotine Dependence (Kornitzer, Boutsen, Dramaix, & Gustavsson, 1995; Sweeney et 
al., 2001; Goldstein, 2003). Many strategies have been employed in the treatment of 
Nicotine Dependence. The most prevalent therapies include pharmacotherapy (e.g., 
Nicotine Replacement Therapy) brief behavior therapy and intensive behavior therapy.  
In addition, to these therapies, some research has focused on the use of regular, 
confectionary, chewing gum as a means to reduce cravings and withdrawal (Britt, Cohen, 
Collins, & Cohen, 2001; Cohen, Collins, & Britt, 1997; Cohen, Britt, Collins, Stott, & 
Carter, 1999; Cohen et al., 2001). Cohen et al. (1997) found that smokers who were given 
the gum reported significantly less global withdrawal. Furthermore, Cohen et al. (2001) 
found that chewing gum while nicotine deprived was associated with lower withdrawal 
symptoms than when not given confectionary gum. While these studies and others like 
them have found support for the use of confectionary gum at decreasing withdrawal 
symptoms, research in this area has relied on self report data. Nothing is known regarding 
the mechanism for this reduction in self-reported withdrawal symptoms. 
One explanation may be that nicotine deprived smokers actually experience an 
increase in parasympathetic nervous system activity. This would indicate that the 
smokers are physiologically more relaxed when chewing gum while in deprivation than 
when not chewing gum while in deprivation. Another explanation may be that individuals 
self report fewer withdrawal symptoms because they expect gum to help. This 
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expectancy may not include a physiological change because participants may simply be 
responding in a socially desirable manner. 
One method of measuring parasympathetic tone is utilizing heart rate variability 
(HRV; Porges, 1992). HRV is the measurement of R-R intervals of the heart and is 
measured in both high frequency (HF) and low frequency (LF; Berston et al., 1997). 
Increased HF HRV is associated with greater variability in heart rate (Berston et al.). 
Greater variability in heart rate is indicative of vagal control of the heart. 
Research on addiction has supported differences among users and non-using 
controls. Ingjaldsson, Laberg, and Thayer (2003) found that alcohol dependent 
individuals have lower HF HRV than non-dependent controls. In addition, research on 
alcohol dependent individuals has also shown a decrease in HF HRV when these 
individuals are confronted with alcohol cues (Rajan, Naga Venkatesha Murthy, 
Ramakrishnan, Gangadhar, & Janakiramaiah, 1998). Finally, research suggests that 
fetuses exposed to cigarette smoking have lower vagal tone (Zeskind & Gingras, 2006).  
While studies exist that have examined HRV as it relates to addiction, there exists 
a dearth of literature examining HRV during withdrawal. In addition, no research exists 
examining the mechanisms that underlie confectionary gum’s role in reducing withdrawal 
symptoms and severity. The aim of the current study is to examine PNS activity as a 
mechanism for understanding how confectionary gum helps reduce withdrawal 
symptoms. It is hypothesized that smokers will experience greater parasympathetic tone 
when given confectionary gum during 24 and 48 hours of nicotine deprivation, as 
indicated by higher HF HRV, compared to 24 and 48 hour deprivation when given no 
chewing gum.
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CHAPTER II 
REVIEW OF THE LITERATURE 
The American Psychiatric Association (APA) groups dependence to all tobacco 
products into one broad category. According to the Diagnostic and Statistical Manual for 
Mental Disorders, Fourth Edition, Text Revised (DSM-IV-TR) Nicotine Dependence is 
defined as a maladaptive pattern of nicotine use that leads to clinically significant 
impairment or distress. Individuals who meet the criteria for nicotine dependence also 
may develop a tolerance to nicotine evidenced by increased consumption of nicotine 
(e.g., increasing the number of cigarettes smoked per day). Nicotine dependent 
individuals will also experience withdrawal symptoms as the time since the last dose of 
nicotine increases (APA, 2000). In addition to withdrawal and tolerance, the DSM-IV-TR 
states that it is also necessary for the individual to exhibit a desire or unsuccessful efforts 
to reduce or eliminate smoking behavior. Also individuals with Nicotine Dependence 
continue to use despite obvious health risks (Abrams & Niaura, 2003). 
 While it is necessary to exhibit three or more of the above symptoms to warrant a 
diagnosis (APA, 2000), research suggests that withdrawal may be primary reason for the 
continued use of nicotine (Cohen, Britt, Collins, al’Absi, & McChargue, 2001). 
Symptoms of nicotine withdrawal include: irritability or frustration, anxiety, difficulty 
concentrating, restlessness, decreased heart rate, depressed mood, insomnia, and 
increased appetite or weight gain (Hughes, 1992). 
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Hughes (1992) examined the withdrawal symptoms reported by 178 self-quitters. 
Participants were rated on a number of withdrawal dimensions that are listed above. 
Hughes found that nicotine withdrawal symptoms are time-limited. This suggests most 
withdrawal symptoms peak around 48 hours of deprivation from nicotine. Furthermore, 
many symptom scores returned to precessation levels between 7 and 30 days. In addition, 
this research suggests that withdrawal from nicotine is expected to last for two to four 
weeks. 
 Despite the relatively short duration of withdrawal symptom severity, many 
smokers avoid withdrawal as quickly as two hours following a cigarette (Abrams & 
Niaura, 2003). Research suggests that the primary reason that many smokers avoid 
withdrawal is due to the negatively reinforcing nature of nicotine dependence. 
Essentially, nicotine dependent individuals are able to “self-medicate” by administering 
nicotine to control withdrawal symptoms (Abrams & Niaura). Therefore, individuals are 
able to escape or avoid the aversive effects of nicotine withdrawal by self-administering 
more nicotine. While this is an effective strategy for eliminating withdrawal symptoms, it 
increases the probability that the individual will engage in smoking behavior in the future 
in order to eliminate or avoid withdrawal symptoms. 
 In addition to withdrawal, smokers often report cravings for cigarettes (APA, 
2000). While these cravings are common, there are no current diagnostic criteria for 
cravings within the DSM-IV-TR (Sweeney, Fant, Fagerstrom, McGovern, & 
Henningfield, 2001). While it is not a separate entity from withdrawal, Sweeney et al. 
state that craving can be an indirect, but persistent, measure of nicotine withdrawal. 
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 Avoiding or eliminating withdrawal symptoms is a key focus in the treatment of 
Nicotine Dependence (Kornitzer, Boutsen, Dramaix, & Gustavsson, 1995; Sweeney et 
al., 2001; Goldstein, 2003). Many strategies have been employed in the treatment of 
Nicotine Dependence. The most prevalent therapies include pharmacotherapy (e.g., 
Nicotine Replacement Therapy) brief behavior therapy and intensive behavior therapy. In 
addition, to these therapies, some research has focused on the use of regular chewing gum 
as a means to reduce cravings and withdrawal (Britt, Cohen, Collins, & Cohen, 2001; 
Cohen, Collins, & Britt, 1997; Cohen, Britt, Collins, Stott, & Carter, 1999; Cohen et al., 
2001). These interventions targeting withdrawal will be discussed in turn. 
Treatments for Nicotine Dependence and Withdrawal 
 Behavioral Interventions. Behavioral interventions for nicotine dependence are 
typically broken down into brief and intensive behavior therapy (Abrams, Niaura, Brown, 
Emmons, Goldstein, & Monti, 2003). Brief behavior therapy is delivered in a very short 
amount of time, typically 10 to 15 minutes (Shadel & Niaura, 2003). Intensive behavior 
therapy consists of multiple sessions, often lasting the course of seven weeks (Brown, 
2003). 
 Brief behavior therapy is essentially composed of five key points originally 
developed by the National Cancer Institute (Fiore et al., 2000). These five components 
are better known as the “5 A’s.” Clinicians begin by asking about smoking behavior and 
advise the smoker to quit. Clinicians then assess the smoker’s willingness to quit. If they 
are ready to quit clinicians moves on to step four, if the smoker is not ready to quit 
clinicians utilize motivational interviewing techniques to increase change talk regarding 
willingness to quit (Miller & Rollnick, 2002). Stage four consists of clinicians assisting 
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the smoker in a quit attempt. This consists of setting a quit date and establishing goals to 
be met as the smoker moves toward his or her quit date. During the final stage clinicians 
focus on arranging follow-up appointments in order to track progress and identify 
problem areas as the smoker moves closer to his or her quit date. This whole process can 
take as few as 10 to 15 minutes of contact and can easily be provided by health care 
professionals who are not clinical psychologists (Shadel & Niaura, 2003). While brief 
interventions have found support, they do little to address nicotine withdrawal. Thus, 
many clinicians may suggest the use of Nicotine Replacement Therapy as a part of a 
comprehensive nicotine cessation program (NRT; Bock, Niaura, Neighbors, Carmona-
Barros, & Azam, 2005). 
 While brief interventions have proven effective, more traditional intensive 
behavior therapies have an advantage over pure brief interventions in that they more 
directly address withdrawal symptoms. This is achieved through nicotine fading. Nicotine 
fading consists of reducing nicotine consumption by switching to brands with lower 
nicotine content and/or gradually reducing the number of cigarettes smoked daily as the 
smoker moves toward the pre-arranged quit date (Becoña & García, 1993; Brown, 2003).  
Pharmacotherpy Treatments. Pharmacotherapy treatments for nicotine 
dependence consist of Nicotine Replacement Therapy (NRT). Current NRT’s approved 
by the Food and Drug Administration (FDA) include nicotine gum, transdermal patch, 
nasal spray, and the nicotine inhaler (Sweeney, Fant, Fagerstrom, McGovern, & 
Henningfield, 2001). 
The most common first-line pharmacotherapies for Nicotine Dependence are of 
the over-the-counter variety. NRT’s have been established as an effective treatment for 
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Nicotine Dependence. NRT’s work to reduce the withdrawal and craving symptoms 
associated with nicotine deprivation. Sweeney et al. (2001) found that utilizing NRT’s 
can double the chance of long-term smoking cessation. 
Research has supported oral NRT’s for reducing urge to smoke (Demazieres et 
al., 2006). In addition, gum NRT has been shown to reduce cued-induced cravings 
(Shiffman, et al., 2003). Also, Shiffman, Ferguson, Gwaltney, Balabanis, and Shadel 
(2006) found that high-dose NRT (via the nicotine patch) can significantly reduce 
withdrawal and cravings produced by 24 and 48 hour abstinence. 
Sweeney et al. (2001) suggest that the best way to utilize the benefits of NRT’s 
may be to combine both the fast and slow administration of nicotine. This suggests that is 
effective to administer slow release NRT’s (i.e., nicotine patch) to provide a stable rate of 
nicotine in the system and to administer fast acting NRT’s (i.e., nicotine gum or lozenge) 
to help control “breakthrough cravings” (Fagerstrom, Schneider, & Lunell, 1993). 
Kornitzer, Bousten, Dramaix, Thijs, & Gustavsson (1995) compared groups of 
participants all of whom smoked 10 or more cigarettes in a day. Kornitzer et al. grouped 
participants into one of three groups: active patch plus active gum, active patch plus 
placebo gum, and placebo patch plus placebo gum. Their results support the use of 
combination treatments; finding significantly higher abstinence rates in the combined 
active group compared to the other two groups at 12 week and 24 week follow-up.  
Another interesting finding from this study was that the active patch/placebo gum 
group only achieved significantly greater abstinence rates at 12 weeks when compared to 
the placebo patch/placebo gum group. This derives two possible implications. One, the 
nicotine patch is as effective as placebo in achieving abstinence in participants (which is 
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clearly not supported in the literature). Two, that the process of chewing gum (nicotine or 
confectionary) has a benefit for the smoker in promoting abstinence to such a degree that 
it makes observing the difference in abstinence rates between placebo patch and nicotine 
patch at 24 and 36 weeks difficult. It is the later implication that is of interest to the 
present study. 
Similarly, Shiffman et al. (2003) included a placebo confectionary gum condition 
in their study of the acute administration of nicotine gum during cue-provoked craving. 
The results suggested that individuals in the confectionary gum condition received some 
craving reduction when chewing the placebo gum. This finding is consistent with a body 
of literature that supports the use of confectionary gum to reduce withdrawal and craving 
symptoms. 
Confectionary Gum. The use of confectionary gum in the treatment of Nicotine 
Dependence has received some support in recent years. Although it does not provide 
nicotine to the abstinent smoker, it has been shown to reduce the withdrawal and cravings 
that are considered to be important reasons for relapse. The research in this area has 
found support for the use of confectionary gum in the reduction of affective stress to 
more specific withdrawal symptoms and craving (Britt et al., 2001; Cohen et al., 1997; 
Cohen et al.,1999; Cohen et al., 2001). 
Cohen et al. (1997) investigated the effect of confectionary gum on self reported 
craving and global withdrawal symptoms in smokers who had been abstinent from 
nicotine while watching a movie. Participants were then given ratings of cravings and 
withdrawal following the movie (Time 1) and again 30 minutes after the time 1 measures 
(Time 2). The results indicated that smokers who were given the gum reported 
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significantly less global withdrawal at time 1 and time 2. In addition, these participants 
also reported significantly less cravings at time 2, but not time 1. A similar study found 
that when smokers are given the choice to choose between gum plus a reward or a 
cigarette they take fewer puffs and wait longer to have their first cigarette (Cohen et al., 
1999). 
Cohen et al. (2001) continued this line of research by examining withdrawal 
symptoms of participants as they completed two separate conditions: a confectionary 
gum condition and a no gum condition. Participants were asked watch a two hour movie 
to establish enough latency between cigarettes for them to experience withdrawal. Self-
report withdrawal symptoms were monitored directly following the movie, 30 minutes 
after the movie, and again 60 minutes after the movie. The results indicated that chewing 
gum while nicotine deprived was associated with lower withdrawal symptoms at 150 
minutes of deprivation and again at 180 minutes of deprivation. These findings support 
the use of confectionary gum as a means to decrease the withdrawal symptoms associated 
with nicotine deprivation. 
Britt et al. (2001) attempted to add support to the above findings. The researchers 
recruited participants to engage in a contrived public speaking stressor task. During the 
task participants were assigned to either a smoke group, a gum group, or a control group. 
Participants were then asked to self-report their urge to smoke, their withdrawal 
symptoms, and their anxiety symptoms at five distinct time intervals through-out the task. 
The results indicated that although being able to smoke was the best for decreasing urge 
to smoke, chewing confectionary gum was as effective as smoking at time 5 in reducing 
withdrawal symptoms. There were no significant effects on anxiety symptoms.  
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While these studies support the efficacy of confectionary gum as a tool to 
decrease withdrawal symptoms, there still remains one key problem. Participants in all of 
these studies were self-reporting withdrawal and craving symptoms. It is unclear if these 
results are do to actual physiological changes in the symptoms of withdrawal or simply 
reactivity that may be experienced by participants who are filling out questionnaires that 
may be face valid. Thus it is necessary to examine the reduction of withdrawal in nicotine 
deprived participants using measures that indicate a physiological reduction in symptoms 
that may be related to the stress response that is related to the clinical significant distress 
experienced by withdrawal (see Hughes, 2006). 
Autonomic Nervous System and the Stress Response 
 The autonomic nervous system (ANS) is responsible for maintaining homeostasis 
in the body. The ANS is essentially made-up of two systems; the sympathetic nervous 
system (SNS) and the parasympathetic nervous system (PNS). The SNS is responsible for 
preparing the body for action. This system is regulated by the hypothalamus and brain 
stem, specifically the medulla oblongata (al’Absi, 2006). Conversely, the PNS is 
responsible for returning the body to homeostasis following the activation of the SNS.  
 More specifically, the hypothalamus sends messages, via the pituitary gland, to 
send the hormone cortisol to areas of the body to aid in the glucose metabolism necessary 
for sympathetic activity (Collins, Sorocco, Haala, Miller, & Lovallo, 2003). This system 
is better known as the hypothalamic-pituitary-adernalcortical (HPA; al’Absi, 2006) axis. 
Once a stressor dissipates the PNS works to return the body to homeostasis by helping to 
reduce the amount of cortisol in the blood, thus reducing heart rate, slowing respiration, 
and stimulating digestion. 
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 The autonomic response is not only activated by life threatening stimuli. It is also 
activated by stress. This is evidenced by increased levels of cortisol in the body when 
individuals are under stress (Lovallo, 2005; al’Absi, 2006). In addition, this cortisol 
response is positively correlated with negative mood states (Ice, 2005). Negative mood 
states associated with the stress response are found among individuals with nicotine 
dependence while under deprivation (Cohen et al., 2001). 
 The fight or flight response stimulated by the SNS is related to increases in heart 
rate associated with the presence of a stressor. Therefore, it is possible to monitor PNS 
activity by examining reductions in heart rate. Researchers have discovered that 
chemically blocking the vagus nerve (e.g., the use of atropine) leads to dramatic increase 
in heart rate (Kawachi, 1997). This highlights the role of vagal control over the heart rate 
and alludes to the connection between the PNS and heart rate. 
 Porges (1992) elaborates on the above assertion. Porges stated that the SNS 
responds to external stimuli and the PNS works to return the body to homeostasis by 
responding to the changes in the viscera created by SNS activity. Therefore, in the 
absence of stressors (e.g., withdrawal symptoms) increased PNS activity may represent 
homeostasis.  
Respiratory Sinus Arrhythmia and Heart Rate Variability 
 Possibly the best index of PNS tone, or vagal control, is obtained through heart 
rate patterns (Porges, 1992). Analyzing heart rate rhythms is a non-invasive process of 
measuring autonomic control (Kobayashi, Ishibashi, & Noguchi, 1999). Although the use 
of an electrocardiogram (ECG) was essential for this purpose, recent advances in exercise 
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technology have made it possible to analyze heart rate with a portable monitor worn 
around the torso.  
 Respiratory Sinus Arrhythmia. Essential to the study of parasympathetic activity 
of the heart is the respiratory sinus arrhythmia (RSA). The relationship between RSA and 
parasympathetic activity has been noted for over 30 years (Katona & Jih, 1975). The 
RSA is primarily controlled by respiratory gating of parasympathetic signals to the heart 
via the vagus nerve (Grossman, 1992). Specifically, parasympathetic signals to the heart 
that work to reduce heart rate are blocked during inspirations and are enabled during 
expiration.  
 RSA has proven to be beneficial in the study of the stress response. Lane, 
Adcock, and Burnett (1992) noted that differences in RSA may play a role in how 
individuals respond to stressors and how quickly they recover. Lane et al. found that 
individuals with greater variability between heartbeats while at rest experienced less 
sympathetic arousal and greater parasympathetic activity during the sympathetic 
response. 
 Heart Rate Variability. The above mentioned variability in beat to beat interval of 
the RSA is most commonly referred to as heart rate variability (HRV; Grossman, 1990; 
Kobayashi et al., 1999). Kobayashi et al. elaborate on this assertion stating that HRV is 
comprised of the RSA and variability in blood pressure. For the purposes of this paper, 
focus will be given to the former because it is representative of parasympathetic tone 
(Pomeranz et al., 1985). 
 HRV is the measurement of R-R intervals of the heart. HRV refers to the 
frequency of these intervals. These intervals have both a low frequency (LF; .04-.15 Hz) 
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and high frequency (HF; .18-.40 Hz) component. The LF band is associated with 
sympathetic activity while the HF band is associated with parasympathetic activity 
(Berston et al., 1997; Kobayashi et al., 1999). For the purposes of this paper focus will be 
given to the HF component of HRV. 
 Berston et al. (1997) discuss the role of HF HRV as it relates to parasympathetic 
activity. Increased HF HRV is associated with greater variability in heart rate. Greater 
variability in heart rate is indicative of vagal control of the heart. Lower HF HRV 
indicates a decrease in HRV and thus less PNS control. Spectral analysis (the analysis of 
heart rate within a discrete period of time) of HRV has been widely discussed as an 
effective method of analyzing HRV (Crawford et al., 1999; Berston et al., 1997; 
Kobayashi et al., 1999; Berston, Cacioppo, & Grossman, 2007). 
 Several factors have been shown to affect HRV. Elsenbruch, Harnish, and Orr 
(1999) found that fluctuations with HRV during wake and sleep cycles. Their results 
indicated a decrease in HF HRV during REM sleep as compared to non-REM sleep. 
Thus, suggesting increased SNS activity and decreased PNS control over heart rate 
during REM sleep. In addition, they discovered that males exhibited significantly lower 
HF HRV during wake cycles, indicating less vagal control compared to females. 
 In addition to sex and sleep studies, some researchers have examined 
psychosocial factors that affect HRV. Horsten et al. (1999) studied the influence of 
psychosocial factors on HRV in women. The results indicated that isolation, low social 
support, and internalizing anger were associated with decreased vagal control. These 
results are similar to those discussed by Lane et al. (1992) that suggest that type B 
personalities have increased HF HRV.  
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 Studies focusing on general medical conditions have produced evidence that 
individuals with coronary problems also experience a decrease in vagal tone. Gianaros et 
al. (2005) found that postmenapausal women experiencing a calcification of blood 
vessels had less parasympathetic tone as evidenced by a decrease in HF HRV. Other 
studies have found that decreased vagal tone significantly predicts death due to heart 
attack (e.g., Kleiger, Miller, Bigger, & Moss, 1987). 
 Research on HRV has also focused on psychological disorders. Thayer, Freidman, 
and Borkovec (1996) found that individuals with GAD had lower HF HRV than non-
anxious controls. In addition, participants instructed to worry had significantly lower HF 
HRV than when instructed to relax. This research suggests that individuals experience 
less vagal control and more SNS activity during worry. Similar finding have been 
discussed for Panic Disorder (Friedman & Thayer, 1998). 
 Research on addiction has supported differences among users and non-using 
controls. Ingjaldsson, Laberg, and Thayer (2003) found that alcohol dependent 
individuals have lower HF HRV than non-dependent controls. In addition, research on 
alcohol dependent individuals has also shown a decrease in HF HRV when these 
individuals are confronted with alcohol cues (Rajan, Naga Venkatesha Murthy, 
Ramakrishnan, Gangadhar, & Janakiramaiah, 1998). Finally, research suggests that 
fetuses exposed to cigarette smoking have lower vagal tone (Zeskind & Gingras, 2006). 
 In addition to the spectral analysis of HRV, statistical analysis has also been 
utilized. Essentially, this consists of examining the overall variability of beat to beat 
intervals (Kleiger, Stein, Bosner, & Rottman, 1992). While the specific HF and LF 
components are not specifically examined, the differences observed are similar; such that 
15
 Several studies have utilized the RMSSD statistic to examine vagal control. For 
example, researchers have demonstrated that compared to normal controls individuals 
with paranoid schizophrenia have significantly less variability in heart rate, suggesting 
less vagal control of the heart (Boettger et al., 2006). Similar findings have been observed 
for women with premenstrual dysphoric disorder (Landén et al., 2004). In addition, 
individuals with depression experienced an increase HRV, as indicated by increased 
RMSSD following cognitive-behavioral therapy (Carney et al., 2000). 
 RMSSD has also been utilized outside the clinical setting. Wang, Huang, and 
Wang (2001) found that enlisted men in the Chinese military exhibiting decreased 
RMSSD during artillery training. This suggests a decrease in parasympathetic, or vagal, 
control during a stressful event. Furthermore this data provides additional support for the 
use of RMSSD as an indicator for examining the presences or absence of 
parasympathetic control and infers that decreases in HRV are associated with the 
sympathetic response.   
 While some research has focused on addiction and cigarette use, there is a 
substantial lack of literature examining HRV in individuals going through withdrawal. 
Research on withdrawal from nicotine has indicated that both nicotine gum and 
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confectionary gum can aid in decreasing self-reported withdrawal symptoms. However, 
none of the aforementioned studies utilized a physiological measure of withdrawal. Due 
to the similarities between withdrawal symptoms and the stress response it stands to 
reason that HRV could be utilized as a physiological marker for stress.  
 The aim of the current study is to examine if PNS activity is a mechanism for 
understanding how confectionary gum helps reduce withdrawal symptoms. It was 
hypothesized that smokers will display greater variability in RR intervals (indicating 
greater parasympathetic tone) when given confectionary gum during 24 and 48 hours of 
nicotine deprivation than when given no gum. More specifically, participants will exhibit 
a greater RMSSD HRV during the gum conditions and a smaller RMSSD during the no 
gum condition. With respect to the spectral analysis component of HRV it was 
hypothesized that participants would experience greater HF HRV during the gum 
conditions than during the no gum condition. 
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CHAPTER III 
METHODOLOGY 
Participants 
 Participant data was analyzed from a previous study of 49 participants who were 
solicited from Texas Tech University and Oklahoma State University and the 
surrounding communities of the two universities (Cohen, VanderVeen, Weaver, & 
Collins, 2007). At Texas Tech University, 63 individuals were scheduled to participate in 
the current study.  Of these sixty-three individuals, 28 completed the experimental 
protocol (22 men, 6 women), 19 never presented for their initial interview after agreeing 
to participate (11 men, 8 women) and 16 individuals began the protocol but dropped out 
before completion (11 men, 5 women).  At Oklahoma State University, 57 individuals 
were scheduled to participate in the current study. Of these 57 individuals, 21 completed 
the experimental protocol (11 men, 10 women), 21 never presented for their initial 
interview (7 men, 14 women), and 15 individuals began the protocol but dropped out 
before completion (5 men, 10 women).
These participants did not differ in number of pieces chewed by condition, F(1, 
47) = .219, p = .64, or gender, F(1, 47) = .70, p = .41. Of these participants, 41 provided 
heart rate data. The participants ranged in age from 18 to 39. All participants met the 
DSM-IV-TR criteria for nicotine dependence and scored at or above a 5 on the 
Fagerstrom Test of Nicotine Dependence (Fagerstrom, 1978). In addition, all participants 
smoked 16 cigarettes or more per day and were willing to chew gum upon request. All
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 participants were reimbursed 50 dollars per week for four weeks with an additional 100 
dollar bonus for completing the study. Thus, participants were reimbursed 300 dollars for 
completing the study. Funding for reimbursement came from a research grant provided 
by the Wrigley Company. 
Materials and Apparatus 
Fagerström Test of Nicotine Dependence (FTND). The FTND is a 6-item self-
report measure of nicotine dependence. Scores range from 0 to 10, with higher scores 
indicating more severe nicotine dependence (Fagerström, 1978). 
DSM IV Screening. The DSM IV screening consisted of a structured interview of 
the DSM criteria for Nicotine Dependence (APA, 2000). Participants were asked  
questions such as “over time did you smoke a lot more to the same effect as before?” 
Participants had to meet at least three of the seven criteria list in the DSM. 
Gum Use Monitoring Form. A gum use monitoring form was given to participants 
for each day of every trial. The form was used as a log of gum chewing activity and 
recorded the time, number of pieces chewed, and behavior engaged while chewing the 
gum. In addition to the self-monitoring, the form acted as a prompt to remind participants 
that gum could be chewed during cravings for nicotine. 
Carbon Monoxide Monitoring. The carbon monoxide (CO) monitor was utilized 
as a means to ensure that our participants were in deprivation throughout each trial. CO 
readings, via a Vitalograph CO breathalyzer, were utilized to ensure that all participants 
had smoked frequently enough prior to the study in order to qualify. This required 
participants to have at least 10 ppm of CO in their blood. In addition to screening, the CO 
monitor ensured that the smokers had maintained abstinence during each trial to ensure 
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that they were experiencing deprivation. Thus participants had to have less than 10 ppm 
CO in their blood or have a 50% reduction in CO reading during the deprivation periods. 
The above parameters were set by the Society for Research on Nicotine and Tobacco’s 
(SRNT) Subcommittee on Biochemical Verification (Benowitz et al., 2002).  
Heart Rate Monitor. Participants’ parasympathetic tone was analyzed using a 
Polar 810s Exercise Heart Rate Monitor. The monitor is a thin band that was worn around 
the torso across the Xiphoid Process. In addition to the band, a watch was worn on the 
wrist that monitors and records the heart rate data gathered from the heart rate band. 
Upon completion of the heart rate recording the data from the wrist unit was synced to a 
computer where the data was entered and saved. Use of this particular exercise heart rate 
monitor has been shown to be in strong agreement with the more commonly used ECG 
recording device. Kingsley, Lewis, and Marson (2005) found a strong linear relationship 
between the Polar 810s and a digital ambulatory ECG (r(6436) = .93, p < .001 to r 
(1746)= .99, p < .001). Finally, all data was then cleaned for imperfections in the 
recording procedure. 
HRV software. Additional software was needed in order to conduct the spectral 
and statistical analysis of the heart rate data. Kubios HRV Analysis version 2.0 beta 
(Tarvainen & Niskanen, 2005) was utilized in order to determine the variability between 
RR intervals. This software allowed researchers to analyze specific time domains and 
extract statistical analyses such as RMSSD  and HF HRV data (Chellakumar, Brumfield, 
Kunderu, & Schopper, 2005; Niskanen, Tarvainen, Ranta-aho, & Karjalainen, 2002).  
Confectionary Gum. The confectionary, non-nicotine, gum was provided by the 
Wrigley Company. Three different flavors of gum were utilized for the three different 
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gum trials. Flavors were labeled by number, not flavor in order to keep participants blind 
to gum ingredients as the flavors used were not for sale by the manufacturer. While the 
participants were blind to gum flavor, the flavors were mint, vanilla, and apple-
cardamom. Gum was disbursed in silver zip-sealed packets of 20 pieces. 
Procedure 
 Participants were recruited via newspaper advertisements and referral from 
former participants. After the initial contact a phone interview was conducted in order to 
determine eligibility. If the potential participant had a FTND score of 5 or more, met 
DSM criteria for nicotine dependence, fit the age range, smoked 16 or more cigarettes 
daily, and was willing to chew gum he or she was given further information regarding the 
study. 
 These participants were then informed that the study would be conducted over a 
four week period during which they would be asked to quit smoking in four, 48 hour 
increments (one period of deprivation per week for four weeks). Willing participants 
were then scheduled for an initial session that began by checking CO levels to determine 
if the participant smoked regularly prior to participation in order to be able to experience 
deprivation during the 48 hour periods of abstinence. Participants with 10 ppm or more 
CO were allowed to continue in the study. 
 At the initial session participants were randomly assigned to one of four 
conditions: no gum, vanilla gum, apple-cardamom gum, and peppermint gum. Individuals 
would participate in all four conditions over a four week period. Each participant would 
receive a new condition that would consist of one of the gum flavors (one flavor per week 
for three weeks) and one no gum (control) week. Participants were then informed that the 
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gum that they would be receiving was non-nicotine gum, but was not a flavor that they 
could necessarily find in a store and that substituting a store bought gum was 
unacceptable.  
Participants then completed a demographic survey and were administered the 
FTND and DSM screener. Participants were then instructed to put on the heart rate 
monitor and watch. Once the heart rate monitor was in place the participants were asked 
to remain seated for 20 minutes during which time they completed other questionnaires 
not essential to this particular investigation. After 20 minutes had expired the participants 
were asked to engage in an orthostatic challenge for 5 minutes (participants instructed to 
stand for 5 minutes) designed to create sympathetic arousal. The purpose of the 
orthostatic challenge was to provide a control comparison of HRV. Standing from a rest 
state eliminates parasympathetic tone and serves as a control comparison of HRV 
analysis across the conditions. 
 Following this period participants were asked to refrain from smoking cigarettes 
or using other nicotine products for 48 hours. The participants were then given the flavor 
of gum assigned for that week or no gum if that was the conditioned assigned. 
Participants were then instructed to refrain from using other confectionary products 
including other gums, candies, or breath strips.  
 Participants returned to the lab at the same time the next day. This allowed 
researchers to assess for adherence and obtain 24 hour deprivation measures. Participants 
began by taking a CO reading. If participants had experienced a 50% reduction in CO 
levels or had a CO level below 10 ppm, they were invited to stay to provide 24 hour 
deprivation heart rate data. Heart rate data collection followed the same protocol listed 
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above. Those who did not meet this criterion were assumed to have not abstained from 
smoking and were asked to come back the following week to restart the condition. 
Participants who completed the heart rate recording were given more gum if needed and 
scheduled to come in at the same time the following day. 
 On day three participants returned to the lab to provide heart rate data for 48 hour 
deprivation. Again participants were asked to provide a CO measurement to check for 
abstinence and continued deprivation. Following the heart rate protocol participants were 
instructed to return to normal smoking behavior until the following week when they were 
to return to the lab to begin the next assigned condition.  
Weeks two through four followed week 1 protocol. Participants stayed in the 
experiment until they had completed all four conditions. Each week participants received 
a new condition (gum or no gum control). Participants completed each condition only 
once. 
Once heart rate data was collected using the Polar exercise software, the heart rate 
data was cleaned of errors that occurred during recording and saved as a new file for 
separate analysis. Heart rate analysis was conducted using only the final 5 minutes of the 
20 minute rest period. This allowed 15 minutes time for the participant to acclimate to the 
heart rate monitor and setting, thus giving the researchers 5 minutes of resting heart rate 
data for analysis. In addition, the orthostatic challenge heart rate data was analyzed for 
comparison to the rest data. 
This data was then converted into a text format as required by the Kubios HRV 
software. Once all data was converted to text files the data was then opened using the 
HRV software. The HRV software provided the RMSSD and HF HRV data that was 
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needed by simply opening a desired text file through the software. Data rendered was 
then entered into SPSS for analyses.
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CHAPTER IV 
 
FINDINGS 
Due to insufficient heart rate data, only 26 of the original 41 participants were 
included in the final analyses. All participants for whom no errors occurred in the HRV 
recording process were included in the sample. Of the remaining 26 participants, 6 
participants were missing data only for baseline data collection. Since no intervention had 
been administered during the baseline phase of each condition, it was decided to average 
the baseline heart rate data from the baselines of each participant’s other baseline 
conditions. This data was entered in the missing data fields for both the HF HRV and 
RMSSD HRV variables. Therefore, all other participants from the original study (Cohen 
et al., 2007) were not included in the analyses of the current study. The hypotheses of the 
current study were tested using only the 26 participants with complete heart rate data. 
 All data was analyzed using within subjects planned contrasts. Due to the small 
sample size contrasts provided a reasonable solution to power difficulties (Venter & 
Maxwell, 1999). Consistent with our stated hypotheses, the planned contrasts made it 
possible to analyze the data by comparing the no gum condition to the three gum 
conditions. Therefore, analysis was conducted by statistically collapsing the three gum 
conditions in order to analyze the difference in HRV between confectionary gum and no 
gum. Finally, separate analyses were conducted for each of the phases (baseline, 24 hour 
deprivation, and 48 hour deprivation).
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 Participant demographics of this sample were consistent with those observed in similar 
research examining nicotine withdrawal in smokers (Cohen et al., 2001). The average 
number of cigarettes smoked per day by the sample was almost 19 cigarettes (M = 18.85, 
SD = 5.10). The participants had an average score of 6 (SD = 1.44) on the FTND, 
indicating an adequate level of nicotine dependence. In addition participants did not 
differ in total number of pieces of gum chewed between gum 1 and gum 2 (t(25) = 1.14, p 
= .266), gum 1 and gum 3 (t(25) = .028, p = .978), and gum 2 and gum3 (t(25) = -.942, p 
= .355). 
 Within subjects planned contrasts revealed no significant differences between the 
gum and no gum conditions for the HF HRV variable at baseline (F(1, 25) = .741, p = 
.398, partial eta squared = .03, observed power = .16). Similar results were observed at 24 
of deprivation, F(1, 25) = .084, p = .775, partial eta squared = .00, observed power = .05. 
However, there was a significant difference between the gum and no gum conditions at 
48 hours deprivation (F(1, 25) = 4.48, p = .04, partial eta squared = .15, observed power 
= .52) such that there was significantly larger HF HRV during the no gum condition and 
the gum conditions (see Table 1 for means and standard deviations). In addition, the 
orthostatic challenge displayed no differences across recording phases, indicating that the 
challenge provided an attenuation of the HF HRV spectrum (see Figure 1). 
 With respect to the time domain (RMSSD) data, no significant differences were 
observed between the gum and no gum conditions at baseline, F(1, 25) = .121, p = .730, 
partial eta squared = .00, observed power = .05. In addition, no differences were observed 
at 24 and 48 hour of deprivation, F(1, 25) = .696, p = .412, partial eta squared = .03, 
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observed power = .16, and F(1, 25) = .163, p = .690, partial eta squared = .01, observed 
power = .06, respectively. However, visual analysis of the means (see Figure 2) suggests 
that participants had greater HRV, as indicated by larger RMSSD, during the gum 
conditions than the no gum condition (see Table 2 for means and standard deviations). 
However, Figure 2 demonstrates that the orthostatic challenge did not attenuate the 
RMSSD of HRV at 24 and 48 hours deprivation. This is likely due to the nature of 
obtaining an overall, “big picture,” statistical analysis of variability within the heart rate.
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CHAPTER V 
 
CONCLUSION 
The purpose of this study was to determine if parasympathetic nervous system 
activity is an effective mechanism by which confectionary chewing gum has its effect on 
self-reported withdrawal symptom attenuation. It was hypothesized that nicotine 
dependent participants would display higher HF HRV during the confectionary gum 
conditions than during the no gum condition during 24 and 48 hours of deprivation. It 
was also hypothesized that these participants would demonstrate greater variability in RR 
intervals (greater RMSSD) during the confectionary gum conditions than during the no 
gum condition. Results of this study suggest that the participants did not experience 
significantly greater parasympathetic activation (greater vagal control of the heart) when 
given confectionary gum compared to when they were given no gum. 
 Although these results are non-significant, it is interesting that the means 
represented for each dependent variable suggests a trend toward a different outcome. 
While the significant HF HRV data would suggest that the no gum conditioned produced 
greater parasympathetic control, the effect size was quite small. Conversely, the RMSSD 
data would suggest greater parasympathetic control during the confectionary gum 
conditions; however, the differences were not significant.  
       While this appears to suggest that the results are contradictory, there is some 
evidence to suggest that these results are encouraging. Malik and colleagues (1996) stated 
that spectral analysis (HF analysis) of HRV can be difficult to determine if the individual
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is not stationary. Although our participants were sitting down, they were chewing gum. 
Therefore chewing gum during the trial may have actually created artifact in the data by 
disrupting the spectral components of the heart rate. In addition, participants were asked 
to fill out forms related to another study regarding withdrawal symptoms and mood 
during the heart rate recording procedure. This may have also affected the participants’ 
autonomic response by forcing the participants to reflect on their emotional states at the 
time of recording. 
Conversely, the statistical methods used during the data recording period do not 
focus solely on one spectral component of HRV. The RMSSD data views the sampled 
HRV data and computes the general variation in the total HRV regardless of the LF and 
HF spectrum. This statistical method of analyzing short-term periods of HRV may be 
more representative of the participant’s vagal tone during the recording. Although this 
provides an explanation for the observed results, it is still largely speculative at this point 
and further research is needed. 
 Regardless, the RMSSD data remains promising. While the data was non-
significant, the displayed means suggest that confectionary chewing gum may play a role 
in activating the parasympathetic nervous system. In addition, the non-significant 
findings may reflect the limitations of the study such as small sample size and 
experimenter error as opposed to the absence of parasympathetic control. 
 There is, however, an alternative explanation of the findings that warrants some 
discussion. It is possible that these data are non-significant because confectionary 
chewing gum does not produced activation of the parasympathetic nervous system. This 
is to say that chewing confectionary gum does not reduce physiological signs of 
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withdrawal, such as sympathetic nervous activity, or the attenuation of sympathetic 
arousal via activation of the parasympathetic branch. This conclusion is inconsistent with 
the findings in previous studies examining the effect of confectionary gum on withdrawal 
and cravings that suggest that chewing gum does ameliorate withdrawal and cravings 
(Britt et al., 2001; Cohen et al., 1997; Cohen et al.,1999; Cohen et al., 2001). If this 
conclusion is true, it would suggest that previous research in this area has demonstrated 
that confectionary gum provides relief to the extent that participants expect confectionary 
gum to help, so they report that it was efficacious relative to the no gum condition. 
Again, this conclusion is speculative and, given the limitations of the study, further 
research is clearly necessary. 
Limitations 
 Despite the non-significant findings, this study had some important limitations. 
The limitations most crucial to this discussion are those of experimenter error and small 
sample size. Each of these limitations will be discussed in turn. 
 The first limitation is the possible role of experimenter error. There is no doubt 
that experimenter error and apparatus malfunction led to the loss of necessary heart rate 
data prior to analyses, but it is possible that additional errors were made. Specifically, the 
protocol called for the participants to chew gum during the heart rate recording phase; 
however, only a small number of adherence checks were conducted during the data 
collection phase and it is possible that not all participants were chewing gum during the 
recording phase. While this would eliminate the artifact hypothesis regarding the HF 
HRV data, it may have led to a decrease in HF HRV during the recording if the actual 
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behavior of chewing gum does not attenuate the parasympathetic response (as inferred 
from the artifact hypothesis).  
The second, and most salient, limitation is that of sample size. From the original 
41 participants, only 26 were able to be utilized in the final analyses due to insufficient 
heart rate data. This limits the power of the study substantially even for a within subject 
design. A separate power analysis was conducted to determine how many participants 
would have been necessary to reach significance even at a small effect size. This analysis 
suggested that a study of this type would require 36 participants to achieve significant 
findings (p < .05) with a small effect size (d = .25). As indicated by the results, our 
existing sample of 26 participants had very little power and very small effect sizes. 
Furthermore, the current study ran separate analyses at each time period. Even with the 
inflated alpha that results from multiple tests, the results are non-significant. Although it 
is inappropriate to infer a direction or trend from the observed means, more participants 
would clearly be helpful in determining whether or not these observed means are toward 
or further away from significance. Therefore additional research is needed. 
  It is necessary that additional research address many of these limitations. For 
example, further researchers should address the faults in the experimental design. Due to 
the possible confound created by chewing gum and completing self report measures of 
withdrawal and mood states during the recording phase, researchers should eliminate the 
demands placed on participants during the protocol. This would optimize the degree to 
which researchers could conclude that the participants were truly relaxed during the 
recording procedure. 
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 In addition, it may be helpful to use more than one measure of physiological 
arousal. While heart rate may be affected by chewing gum, it is possible that changes at 
the neurological level may occur. The use of neuroimaging techniques may provide an 
excellent method for discriminating physiological changes in emotion across the 
conditions. Also, more behavioral measures could be helpful. Ekman and Friesen (1976) 
suggested a code for identifying facial movements, this may be an additional marker of 
the emotional response of stress and it may relate to withdrawal induced stress (Ekman, 
Levenson, & Friesen, 1983).  
 Finally, it should be noted that reducing human emotion (e.g., withdrawal-induced 
stress states) to physiology discounts the complexity of human emotion. While past 
research supports the use of confectionary gum to reduce self-reported withdrawal, it is 
unclear as to whether PNS activity is a mechanism for understanding this phenomenon. It 
is stands to reason that the withdrawal response has both a physiological and a 
psychological component that cannot, and should not, be observed independently from 
the other. 
Conclusion 
 The purpose of this study was to determine if autonomic activity, specifically 
parasympathetic control of the heart, is a mechanism by which confectionary chewing 
gum decreases withdrawal symptoms in nicotine deprived smokers. Results suggest that 
confectionary gum did not have a significant effect on the vagal control of the heart as 
indicated by non-significant differences in the variability of the RR intervals. Significant 
differences were found at 48 hour deprivation for HF HRV, suggesting that no gum may 
lead to greater parasympathetic nervous system activity than actually chewing gum. 
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While this result appears troublesome because it is in the opposite direction as expected, 
it is likely due to the effect of a motor behavior (i.e., chewing gum) may have on spectral 
analysis of heart rate. Therefore, we suggest that the RMSSD data is more representative 
of the parasympathetic activity (vagal control) observed within the sample. 
 The RMSSD data did not yield significant differences between gum and no gum 
conditions; however, the means suggest that there is greater variability in heart rate 
during the gum conditions than during the no gum condition. Further research is 
necessary to determine the extent to which chewing confectionary gum affects autonomic 
responses. This line of research should include larger samples, more frequent adherence 
checks to ensure accurate data collection, fewer demands placed on participants during 
the heart rate recording procedure, and additional physiological or behavioral measures of 
withdrawal.
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APPENDIX A 
 Table 1 
 HF HRV Means and Standard Deviations 
 Baseline 24 hour 48 hour 
Condition M SD M SD M SD 
 
No Gum 
 
 
.275 
 
.056 
 
.264 
 
.043 
 
.277 
 
.057 
Gum 1 
 
.264 .065 .273 .061 .261 .064 
Gum 2 
 
.261 .068 .282 .058 .258 .062 
Gum 3 
 
.270 .067 .247 .062 .245 .045 
Combined Gum 
 
.265 .067 .267 .060 .255 .057 
 Note. HF HRV data are presented in Hz. 
 
 Table 2 
 RMSSD Means and Standard Deviations 
 Baseline 24 hour 48 Hour 
Condition M SD M SD M SD 
 
No Gum 
 
 
27.05 
 
16.865 
 
46.01 
 
23.58 
 
44.94 
 
27.13 
Gum 1 25.30 17.432 57.69 32.48 47.85 24.89 
Gum 2 29.04 21.397 45.05 22.82 42.52 23.40 
Gum 3 29.88 24.65 44.34 30.37 50.76 31.86 
Combined Gum 28.07 21.15 49.03 28.56 47.03 26.72 
 Note. RMSSD data is presented in ms. 
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Figure 1. HF HRV observed means for the resting heart rate phase and orthostatic 
challenge. Gum conditions have been collapsed to more accurately represent the 
conducted analysis. 
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Figure 2. RMSSD HRV observed means for the resting heart rate phase and orthostatic 
challenge. Gum conditions have been collapsed to more accurately represent the 
conducted analysis. 
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